James M. Daly, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 30,000 shares at $22.37 ($671K) on 2025-11-10, disclosed to the SEC on 2025-11-12.
Open-market sale of $671k ACAD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HALO | SELL | 2023-08-15 | $875K | — | Filing → |
| HALO | SELL | 2020-11-25 | $838K | — | Filing → |
| HALO | SELL | 2020-08-13 | $2.0M | — | Filing → |